United States · Markets & Finance · Yahoo Finance

MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)

Published by Yahoo Finance · United States 10 h ago

Data presentations build on the July 2026 FDA approval and U.S. launch of Furoscix ReadyFlow, the first and only autoinjector delivering IV-equivalent diuretic therapy for heart…

Read the full article on Yahoo Finance Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

TechCrunch

Anthropic can’t reliably control its AI agents. It’s cutting off its internal evals from the live internet instead

Business Insider

An NYU professor says OpenAI's mass release of math papers wiped out early-career researchers' projects

Seeking Alpha

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

CNBC

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

NYT Business

Big Controversy Upends a Contest About Microscopic Videos

OilPrice.com